Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam for Pain in Chronic Idiopathic Axonal Polyneuropathy
NCT00156689Phase 2Completed
- Sponsor
- Vanderbilt University
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic idiopathic axonal polyneuropathy (CIAP) comparing Levetiracetam with Placebo (2 arms). Primary endpoint: Absolute change in average weekly Pain Severity Score at 16 weeks. Started Aug 2005; status: completed.
02
Drugs
levetiracetam
03
Conditions
chronic idiopathic axonal polyneuropathy (CIAP)
Beyond the preview
Go deeper on NCT00156689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00156689.